{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:17:42Z","timestamp":1773076662901,"version":"3.50.1"},"reference-count":51,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1507\/endocrj.ej16-0124","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T18:05:40Z","timestamp":1468001140000},"page":"877-884","source":"Crossref","is-referenced-by-count":59,"title":["The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes"],"prefix":"10.1507","volume":"63","author":[{"given":"Yoshitaka","family":"Hashimoto","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Osaka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhei","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, <i>et al<\/i>. (2009) Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. <i>Diabetes Care<\/i> 32: 1993-1997.","DOI":"10.2337\/dc09-0264"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Srikanthan P, Hevener AL, Karlamangla AS (2010) Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. <i>PLoS One<\/i> 5: e10805.","DOI":"10.1371\/journal.pone.0010805"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, <i>et al<\/i>. (2006) Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. <i>Diabetes<\/i> 55: 1813-1818.","DOI":"10.2337\/db05-1183"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Moon SS (2014) Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. <i>Endocr J<\/i> 61: 61-70.","DOI":"10.1507\/endocrj.EJ13-0244"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kohara K (2014) Sarcopenic obesity in aging population: current status and future directions for research. <i>Endocrine<\/i> 45: 15-25.","DOI":"10.1007\/s12020-013-9992-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chin SO, Rhee SY, Chon S, Hwang YC, Jeong IK, <i>et al<\/i>. (2013) Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. <i>PLoS One<\/i> 8: e60119.","DOI":"10.1371\/journal.pone.0060119"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ (2014) Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. <i>Eur J Clin Nutr <\/i>68: 1001-1007.","DOI":"10.1038\/ejcn.2014.117"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, <i>et al<\/i>. (2014) Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men.<i> J Am Geriatr Soc<\/i> 62: 253-260.","DOI":"10.1111\/jgs.12652"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rasmussen BB, Fujita S, Wolfe RR, Mittendorfer B, Roy M, <i>et al<\/i>. (2006) Insulin resistance of muscle protein metabolism in aging. <i>FASEB J<\/i> 20: 768-769.","DOI":"10.1096\/fj.05-4607fje"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, <i>et al<\/i>. (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. <i>Ann Intern Med<\/i> 143: 722-728.","DOI":"10.7326\/0003-4819-143-10-200511150-00009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, <i>et al<\/i>. (2016) The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. <i>Liver Int<\/i> 36: 275-283.","DOI":"10.1111\/liv.12912"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Park SK, Seo MH, Shin HC, Ryoo JH (2013) Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study. <i>Hepatology<\/i> 57: 1378-1383.","DOI":"10.1002\/hep.26183"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, <i>et al<\/i>. (2014) Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. <i>PLoS Med<\/i> 11: e1001680.","DOI":"10.1371\/journal.pmed.1001680"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, <i>et al<\/i>. (2007) Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. <i>World J Gastroenterol<\/i> 13: 1579-1584.","DOI":"10.3748\/wjg.v13.i10.1579"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Akabame S, Hamaguchi M, Tomiyasu K, Tanaka M, Kobayashi-Takenaka Y, <i>et al<\/i>. (2008) Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). <i>Circ J<\/i> 72: 618-625.","DOI":"10.1253\/circj.72.618"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, <i>et al<\/i>. (2011) Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. <i>Gut<\/i> 60: 1721-1727.","DOI":"10.1136\/gut.2011.242016"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, <i>et al<\/i>. (2014) Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. <i>Hepatology<\/i> 59: 1772-1778.","DOI":"10.1002\/hep.26716"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Moon JS, Yoon JS, Won KC, Lee HW (2013) The role of skeletal muscle in development of nonalcoholic Fatty liver disease. <i>Diabetes Metab J<\/i> 37: 278-285.","DOI":"10.4093\/dmj.2013.37.4.278"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lee YH, Jung KS, Kim SU, Yoon HJ, Yun YJ, <i>et al<\/i>. (2015) Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011). <i>J Hepatol<\/i> 63: 486-493.","DOI":"10.1016\/j.jhep.2015.02.051"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. <i>Diabetes Care<\/i> 36 Suppl 1: S67-S74.","DOI":"10.2337\/dc13-S067"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fukuda Y, Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, <i>et al<\/i>. (2016) Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. <i>Liver Int<\/i> 36: 713-720.","DOI":"10.1111\/liv.12977"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. de L&eacute;dinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B (2012) Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.<i> Liver Int<\/i> 32: 911-918.","DOI":"10.1111\/j.1478-3231.2012.02820.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sasso M, Miette V, Sandrin L, Beaugrand M (2012) The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. <i>Clin Res Hepatol Gastroenterol<\/i> 36: 13-20.","DOI":"10.1016\/j.clinre.2011.08.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, <i>et al<\/i>. (2010) Controlled attenuation parameter (CAP): a novel VCTE<sup>TM<\/sup> guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. <i>Ultrasound Med Biol<\/i> 36: 1825-1835.","DOI":"10.1016\/j.ultrasmedbio.2010.07.005"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Karlas T, Petroff D, Garnov N, B&ouml;hm S, Tenckhoff H, <i>et al<\/i>. (2014) Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. <i>PLoS One <\/i>9: e91987.","DOI":"10.1371\/journal.pone.0091987"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Shah A, Lydecker A, Murray K, Tetri BN, Contos MJ, <i>et al<\/i>. (2009) Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. <i>Clin Gastroenterol Hepatol<\/i> 7: 1104-1112.","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kim M, Shinkai S, Murayama H, Mori S (2015) Comparison of segmental multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body composition in a community-dwelling older population. <i>Geriatr Gerontol Int<\/i> 15: 1013-1022.","DOI":"10.1111\/ggi.12384"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Anderson LJ, Erceg DN, Schroeder ET (2012) Utility of multifrequency bioelectrical impedance compared with dual-energy x-ray absorptiometry for assessment of total and regional body composition varies between men and women. <i>Nutr Res <\/i>32: 479-485.","DOI":"10.1016\/j.nutres.2012.05.009"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Tanimoto Y, Watanabe M, Sun W, Hirota C, Sugiura Y, <i>et al<\/i>. (2012) Association between muscle mass and disability in performing instrumental activities of daily living (IADL) in community-dwelling elderly in Japan. <i>Arch Gerontol Geriatr<\/i> 54: e230-e233.","DOI":"10.1016\/j.archger.2011.06.015"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tanimoto Y, Watanabe M, Kono R, Hirota C, Takasaki K, <i>et al<\/i>. (2010) Aging changes in muscle mass of Japanese. <i>Nihon Ronen Igakkai Zasshi<\/i> 47: 52-57 (In Japanese).","DOI":"10.3143\/geriatrics.47.52"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, <i>et al<\/i>. (2012) Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. <i>World J Gastroenterol<\/i> 18: 237-243.","DOI":"10.3748\/wjg.v18.i3.237"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hashimoto Y, Hamaguchi M, Kojima T, Ohshima Y, Ohbora A, <i>et al<\/i>. (2015) Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study. <i>J Gastroenterol Hepatol<\/i> 30: 546-552.","DOI":"10.1111\/jgh.12786"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ma H, Xu C, Xu L, Yu C, Miao M, <i>et al<\/i>. (2013) Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population. <i>BMC Gastroenterol<\/i> 13: 3.","DOI":"10.1186\/1471-230X-13-3"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sanada K, Miyachi M, Tanimoto M, Yamamoto K, Murakami H, <i>et al<\/i> (2010) A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. <i>Eur J Appl Physiol <\/i>110: 57-65.","DOI":"10.1007\/s00421-010-1473-z"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Nomura T, Ikeda Y, Nakao S, Ito K, Ishida K, <i>et al<\/i>. (2007) Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study. <i>Endocr J<\/i> 54: 791-796.","DOI":"10.1507\/endocrj.K07-055"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Srikanthan P, Karlamangla AS (2011) Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey.<i> J Clin Endocrinol Metab<\/i> 96: 2898-2903.","DOI":"10.1210\/jc.2011-0435"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. O&rsquo;Neill ED, Wilding JP, Kahn CR, Van Remmen H, McArdle A, <i>et al<\/i>. (2010) Absence of insulin signaling in skeletal muscle is associated with reduced muscle mass and function: evidence for decreased protein synthesis and not increased degradation. <i>Age (Dordr)<\/i> 32: 209-222.","DOI":"10.1007\/s11357-009-9125-0"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Mavalli MD, DiGirolamo DJ, Fan Y, Riddle RC, Campbell KS, <i>et al<\/i>. (2010) Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. <i>J Clin Invest<\/i> 120: 4007-4020.","DOI":"10.1172\/JCI42447"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Vincent HK, Raiser SN, Vincent KR (2012) The aging musculoskeletal system and obesity-related considerations with exercise. <i>Ageing Res Rev<\/i> 11: 361-373.","DOI":"10.1016\/j.arr.2012.03.002"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. <i>Curr Mol Med<\/i> 9: 299-314.","DOI":"10.2174\/156652409787847191"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Sumida Y, Yonei Y, Tanaka S, Mori K, Kanemasa K, <i>et al<\/i>. (2015) Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease. <i>Hepatol Res<\/i> 45: 771-781.","DOI":"10.1111\/hepr.12408"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Kato K, Takeshita Y, Misu H, Zen Y, Kaneko S, <i>et al<\/i>. (2015) Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver disease. <i>J Diabetes Investig<\/i> 6: 158-163.","DOI":"10.1111\/jdi.12271"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Fukui M, Kitagawa Y, Ose H, Hasegawa G, Yoshikawa T, <i>et al<\/i>. (2007) Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes. <i>Curr Diabetes Rev<\/i> 3: 25-31.","DOI":"10.2174\/157339907779802094"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Roy TA, Blackman MR, Harman SM, Tobin JD, Schrager M, <i>et al<\/i>. (2002) Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. <i>Am J Physiol Endocrinol Metab<\/i> 283: E284-E294.","DOI":"10.1152\/ajpendo.00334.2001"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Senmaru T, Fukui M, Okada H, Mineoka Y, Yamazaki M, <i>et al<\/i>. (2013) Testosterone deficiency induces markedly decreased serum triglycerides, increased small dense LDL, and hepatic steatosis mediated by dysregulation of lipid assembly and secretion in mice fed a high-fat diet. <i>Metabolism<\/i> 62: 851-860.","DOI":"10.1016\/j.metabol.2012.12.007"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Yoo KD, Jun DW, Lee KN, Lee HL, Lee OY, <i>et al<\/i>. (2015) Sarcopenia is a risk factor for elevated aminotransferase in men independently of body mass index, dietary habits, and physical activity. <i>Dig Liver Dis<\/i> 47: 303-308.","DOI":"10.1016\/j.dld.2014.12.014"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Enns DL, Tiidus PM (2010) The influence of estrogen on skeletal muscle: sex matters. <i>Sports Med<\/i> 40: 41-58.","DOI":"10.2165\/11319760-000000000-00000"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Hewitt KN, Pratis K, Jones ME, Simpson ER (2004) Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. <i>Endocrinology<\/i> 145: 1842-1848.","DOI":"10.1210\/en.2003-1369"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Gutierrez-Grobe Y, Ponciano-Rodr&iacute;guez G, Ramos MH, Uribe M, M&eacute;ndez-S&aacute;nchez N (2010) Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. <i>Ann Hepatol <\/i>9: 402-409.","DOI":"10.1016\/S1665-2681(19)31616-3"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, <i>et al<\/i>. (2005) Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. <i>Diabet Med<\/i> 22: 1141-1145.","DOI":"10.1111\/j.1464-5491.2005.01582.x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Leite NC, Salles GF, Araujo AL, Villela-Nogueira CA, Cardoso CR (2009) Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. <i>Liver Int<\/i> 29: 113-119.","DOI":"10.1111\/j.1478-3231.2008.01718.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/10\/63_EJ16-0124\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T19:01:48Z","timestamp":1568142108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/10\/63_EJ16-0124\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej16-0124","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}